U.S. markets closed
  • S&P Futures

    4,165.00
    +7.25 (+0.17%)
     
  • Dow Futures

    34,339.00
    +83.00 (+0.24%)
     
  • Nasdaq Futures

    13,329.50
    +26.00 (+0.20%)
     
  • Russell 2000 Futures

    2,230.70
    +5.20 (+0.23%)
     
  • Crude Oil

    66.35
    +0.08 (+0.12%)
     
  • Gold

    1,869.50
    +1.90 (+0.10%)
     
  • Silver

    28.39
    +0.12 (+0.41%)
     
  • EUR/USD

    1.2158
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.6400
    +0.0050 (+0.31%)
     
  • Vix

    19.72
    +0.91 (+4.84%)
     
  • GBP/USD

    1.4149
    +0.0011 (+0.08%)
     
  • USD/JPY

    109.2570
    +0.0570 (+0.05%)
     
  • BTC-USD

    43,902.74
    -2,376.73 (-5.14%)
     
  • CMC Crypto 200

    1,199.18
    +1.26 (+0.11%)
     
  • FTSE 100

    7,032.85
    -10.76 (-0.15%)
     
  • Nikkei 225

    27,824.83
    -259.67 (-0.92%)
     

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SOUTH PLAINFIELD, N.J., April 20, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2021 financial results and provide an update on the company's business and outlook on Tuesday, May 4, 2021 at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 4292410. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at https://ir.ptcbio.com/events-presentations. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.

FOR MORE INFORMATION PLEASE CONTACT:

Media:

Investors:

Jane Baj

Kylie O'Keefe

+1 (908) 912-9167

+1 (908) 300-0691

jbaj@ptcbio.com

kokeefe@ptcbio.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2021-financial-results-301269185.html

SOURCE PTC Therapeutics, Inc.